nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—MERTK—Parkinson's disease	0.272	0.409	CbGaD
Bosutinib—LRRK2—Parkinson's disease	0.242	0.364	CbGaD
Bosutinib—ABL1—Parkinson's disease	0.127	0.191	CbGaD
Bosutinib—ABCB1—Parkinson's disease	0.0235	0.0354	CbGaD
Bosutinib—Vandetanib—ABL1—Parkinson's disease	0.00162	0.703	CrCbGaD
Bosutinib—Gefitinib—CYP2D6—Parkinson's disease	0.000398	0.173	CrCbGaD
Bosutinib—Gefitinib—ABCB1—Parkinson's disease	0.000284	0.124	CrCbGaD
Bosutinib—MAP3K12—central nervous system—Parkinson's disease	0.000156	0.00115	CbGeAlD
Bosutinib—HCK—nervous system—Parkinson's disease	0.000156	0.00115	CbGeAlD
Bosutinib—CLK1—nervous system—Parkinson's disease	0.000156	0.00115	CbGeAlD
Bosutinib—PTK2B—head—Parkinson's disease	0.000156	0.00115	CbGeAlD
Bosutinib—ABL1—embryo—Parkinson's disease	0.000155	0.00115	CbGeAlD
Bosutinib—RPS6KB1—spinal cord—Parkinson's disease	0.000155	0.00114	CbGeAlD
Bosutinib—MAP4K4—cerebellum—Parkinson's disease	0.000155	0.00114	CbGeAlD
Bosutinib—STK4—brain—Parkinson's disease	0.000154	0.00114	CbGeAlD
Bosutinib—AXL—spinal cord—Parkinson's disease	0.000154	0.00113	CbGeAlD
Bosutinib—BCR—cerebellum—Parkinson's disease	0.000154	0.00113	CbGeAlD
Bosutinib—NUAK2—cerebellum—Parkinson's disease	0.000154	0.00113	CbGeAlD
Bosutinib—CSNK1E—head—Parkinson's disease	0.000153	0.00113	CbGeAlD
Bosutinib—MAP2K1—central nervous system—Parkinson's disease	0.000153	0.00113	CbGeAlD
Bosutinib—STK35—central nervous system—Parkinson's disease	0.000153	0.00113	CbGeAlD
Bosutinib—BMP2K—nervous system—Parkinson's disease	0.000153	0.00113	CbGeAlD
Bosutinib—CAMK2G—nervous system—Parkinson's disease	0.000153	0.00113	CbGeAlD
Bosutinib—MAP3K12—cerebellum—Parkinson's disease	0.000152	0.00112	CbGeAlD
Bosutinib—CAMK1D—brain—Parkinson's disease	0.000152	0.00112	CbGeAlD
Bosutinib—CSK—central nervous system—Parkinson's disease	0.000152	0.00112	CbGeAlD
Bosutinib—SLK—midbrain—Parkinson's disease	0.000151	0.00112	CbGeAlD
Bosutinib—LRRK2—nervous system—Parkinson's disease	0.000151	0.00112	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—Parkinson's disease	0.000151	0.00111	CbGeAlD
Bosutinib—SIK1—head—Parkinson's disease	0.000151	0.00111	CbGeAlD
Bosutinib—IRAK4—head—Parkinson's disease	0.000151	0.00111	CbGeAlD
Bosutinib—MAP2K5—cardiovascular system—Parkinson's disease	0.000151	0.00111	CbGeAlD
Bosutinib—STK24—brain—Parkinson's disease	0.000151	0.00111	CbGeAlD
Bosutinib—EPHB4—midbrain—Parkinson's disease	0.00015	0.00111	CbGeAlD
Bosutinib—HCK—central nervous system—Parkinson's disease	0.00015	0.00111	CbGeAlD
Bosutinib—CLK1—central nervous system—Parkinson's disease	0.00015	0.00111	CbGeAlD
Bosutinib—STK35—cerebellum—Parkinson's disease	0.000149	0.0011	CbGeAlD
Bosutinib—MAP2K1—cerebellum—Parkinson's disease	0.000149	0.0011	CbGeAlD
Bosutinib—EPHA4—head—Parkinson's disease	0.000149	0.0011	CbGeAlD
Bosutinib—CSK—cerebellum—Parkinson's disease	0.000148	0.00109	CbGeAlD
Bosutinib—SLK—spinal cord—Parkinson's disease	0.000148	0.00109	CbGeAlD
Bosutinib—ERBB3—head—Parkinson's disease	0.000148	0.00109	CbGeAlD
Bosutinib—PTK2B—nervous system—Parkinson's disease	0.000148	0.00109	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—Parkinson's disease	0.000147	0.00109	CbGeAlD
Bosutinib—ULK3—head—Parkinson's disease	0.000147	0.00109	CbGeAlD
Bosutinib—MAP2K2—head—Parkinson's disease	0.000147	0.00109	CbGeAlD
Bosutinib—FYN—midbrain—Parkinson's disease	0.000147	0.00109	CbGeAlD
Bosutinib—CAMK2G—central nervous system—Parkinson's disease	0.000147	0.00109	CbGeAlD
Bosutinib—BMP2K—central nervous system—Parkinson's disease	0.000147	0.00109	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—Parkinson's disease	0.000147	0.00108	CbGeAlD
Bosutinib—EPHB4—spinal cord—Parkinson's disease	0.000147	0.00108	CbGeAlD
Bosutinib—CLK1—cerebellum—Parkinson's disease	0.000146	0.00108	CbGeAlD
Bosutinib—MAP3K2—head—Parkinson's disease	0.000146	0.00108	CbGeAlD
Bosutinib—LRRK2—central nervous system—Parkinson's disease	0.000146	0.00108	CbGeAlD
Bosutinib—FER—brain—Parkinson's disease	0.000146	0.00107	CbGeAlD
Bosutinib—ALK—brain—Parkinson's disease	0.000146	0.00107	CbGeAlD
Bosutinib—TYRO3—brain—Parkinson's disease	0.000146	0.00107	CbGeAlD
Bosutinib—EPHA5—brain—Parkinson's disease	0.000146	0.00107	CbGeAlD
Bosutinib—ABL2—cerebellum—Parkinson's disease	0.000146	0.00107	CbGeAlD
Bosutinib—YES1—medulla oblongata—Parkinson's disease	0.000145	0.00107	CbGeAlD
Bosutinib—CSNK1E—nervous system—Parkinson's disease	0.000145	0.00107	CbGeAlD
Bosutinib—LYN—brain—Parkinson's disease	0.000145	0.00107	CbGeAlD
Bosutinib—MAP3K3—midbrain—Parkinson's disease	0.000144	0.00106	CbGeAlD
Bosutinib—MAP4K5—midbrain—Parkinson's disease	0.000144	0.00106	CbGeAlD
Bosutinib—CAMK2G—cerebellum—Parkinson's disease	0.000144	0.00106	CbGeAlD
Bosutinib—BMP2K—cerebellum—Parkinson's disease	0.000144	0.00106	CbGeAlD
Bosutinib—FYN—spinal cord—Parkinson's disease	0.000144	0.00106	CbGeAlD
Bosutinib—TAOK3—medulla oblongata—Parkinson's disease	0.000144	0.00106	CbGeAlD
Bosutinib—TBK1—head—Parkinson's disease	0.000143	0.00106	CbGeAlD
Bosutinib—PTK2—head—Parkinson's disease	0.000143	0.00106	CbGeAlD
Bosutinib—SIK1—nervous system—Parkinson's disease	0.000143	0.00105	CbGeAlD
Bosutinib—IRAK4—nervous system—Parkinson's disease	0.000143	0.00105	CbGeAlD
Bosutinib—MAP4K1—brain—Parkinson's disease	0.000143	0.00105	CbGeAlD
Bosutinib—MAP3K19—brain—Parkinson's disease	0.000143	0.00105	CbGeAlD
Bosutinib—LRRK2—cerebellum—Parkinson's disease	0.000142	0.00105	CbGeAlD
Bosutinib—ABL1—brainstem—Parkinson's disease	0.000142	0.00105	CbGeAlD
Bosutinib—EGFR—cerebellum—Parkinson's disease	0.000142	0.00105	CbGeAlD
Bosutinib—PTK2B—central nervous system—Parkinson's disease	0.000142	0.00105	CbGeAlD
Bosutinib—BTK—brain—Parkinson's disease	0.000142	0.00105	CbGeAlD
Bosutinib—EPHA4—nervous system—Parkinson's disease	0.000141	0.00104	CbGeAlD
Bosutinib—MAP3K3—spinal cord—Parkinson's disease	0.00014	0.00104	CbGeAlD
Bosutinib—MAP4K5—spinal cord—Parkinson's disease	0.00014	0.00104	CbGeAlD
Bosutinib—ERBB3—nervous system—Parkinson's disease	0.00014	0.00103	CbGeAlD
Bosutinib—TNK2—brain—Parkinson's disease	0.00014	0.00103	CbGeAlD
Bosutinib—CSNK1E—central nervous system—Parkinson's disease	0.00014	0.00103	CbGeAlD
Bosutinib—ULK3—nervous system—Parkinson's disease	0.00014	0.00103	CbGeAlD
Bosutinib—MAP2K2—nervous system—Parkinson's disease	0.00014	0.00103	CbGeAlD
Bosutinib—PTK2B—cerebellum—Parkinson's disease	0.000139	0.00102	CbGeAlD
Bosutinib—MAP3K2—nervous system—Parkinson's disease	0.000139	0.00102	CbGeAlD
Bosutinib—MAP4K2—brain—Parkinson's disease	0.000138	0.00102	CbGeAlD
Bosutinib—RPS6KB1—head—Parkinson's disease	0.000138	0.00102	CbGeAlD
Bosutinib—SIK1—central nervous system—Parkinson's disease	0.000138	0.00101	CbGeAlD
Bosutinib—IRAK4—central nervous system—Parkinson's disease	0.000138	0.00101	CbGeAlD
Bosutinib—FGR—head—Parkinson's disease	0.000137	0.00101	CbGeAlD
Bosutinib—CSNK1E—cerebellum—Parkinson's disease	0.000137	0.00101	CbGeAlD
Bosutinib—AXL—head—Parkinson's disease	0.000136	0.00101	CbGeAlD
Bosutinib—EPHA4—central nervous system—Parkinson's disease	0.000136	0.001	CbGeAlD
Bosutinib—STK3—brain—Parkinson's disease	0.000136	0.001	CbGeAlD
Bosutinib—ERBB4—brain—Parkinson's disease	0.000136	0.001	CbGeAlD
Bosutinib—TBK1—nervous system—Parkinson's disease	0.000136	0.001	CbGeAlD
Bosutinib—PTK2—nervous system—Parkinson's disease	0.000136	0.001	CbGeAlD
Bosutinib—ERBB3—central nervous system—Parkinson's disease	0.000135	0.000995	CbGeAlD
Bosutinib—MAP2K2—central nervous system—Parkinson's disease	0.000135	0.000992	CbGeAlD
Bosutinib—ULK3—central nervous system—Parkinson's disease	0.000135	0.000992	CbGeAlD
Bosutinib—SIK1—cerebellum—Parkinson's disease	0.000134	0.000992	CbGeAlD
Bosutinib—IRAK4—cerebellum—Parkinson's disease	0.000134	0.000992	CbGeAlD
Bosutinib—ROCK1—brain—Parkinson's disease	0.000134	0.000991	CbGeAlD
Bosutinib—MAP3K2—central nervous system—Parkinson's disease	0.000134	0.000985	CbGeAlD
Bosutinib—EPHA4—cerebellum—Parkinson's disease	0.000133	0.000982	CbGeAlD
Bosutinib—YES1—midbrain—Parkinson's disease	0.000133	0.000981	CbGeAlD
Bosutinib—ERBB3—cerebellum—Parkinson's disease	0.000132	0.000972	CbGeAlD
Bosutinib—MAP2K2—cerebellum—Parkinson's disease	0.000131	0.00097	CbGeAlD
Bosutinib—ULK3—cerebellum—Parkinson's disease	0.000131	0.00097	CbGeAlD
Bosutinib—TAOK3—midbrain—Parkinson's disease	0.000131	0.000968	CbGeAlD
Bosutinib—TBK1—central nervous system—Parkinson's disease	0.000131	0.000965	CbGeAlD
Bosutinib—PTK2—central nervous system—Parkinson's disease	0.000131	0.000965	CbGeAlD
Bosutinib—RPS6KB1—nervous system—Parkinson's disease	0.000131	0.000964	CbGeAlD
Bosutinib—MAP3K2—cerebellum—Parkinson's disease	0.000131	0.000963	CbGeAlD
Bosutinib—BMPR2—brain—Parkinson's disease	0.00013	0.000963	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—Parkinson's disease	0.00013	0.000962	CbGeAlD
Bosutinib—FGR—nervous system—Parkinson's disease	0.00013	0.000958	CbGeAlD
Bosutinib—YES1—spinal cord—Parkinson's disease	0.00013	0.000957	CbGeAlD
Bosutinib—STK36—brain—Parkinson's disease	0.000129	0.000955	CbGeAlD
Bosutinib—EPHB3—brain—Parkinson's disease	0.000129	0.000955	CbGeAlD
Bosutinib—AXL—nervous system—Parkinson's disease	0.000129	0.000954	CbGeAlD
Bosutinib—MAP3K7—cerebellum—Parkinson's disease	0.000129	0.000954	CbGeAlD
Bosutinib—MAP2K5—medulla oblongata—Parkinson's disease	0.000129	0.00095	CbGeAlD
Bosutinib—TAOK3—spinal cord—Parkinson's disease	0.000128	0.000945	CbGeAlD
Bosutinib—MERTK—brain—Parkinson's disease	0.000128	0.000944	CbGeAlD
Bosutinib—EPHA2—head—Parkinson's disease	0.000128	0.000944	CbGeAlD
Bosutinib—TBK1—cerebellum—Parkinson's disease	0.000128	0.000943	CbGeAlD
Bosutinib—PTK2—cerebellum—Parkinson's disease	0.000128	0.000943	CbGeAlD
Bosutinib—FYN—head—Parkinson's disease	0.000128	0.000942	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—Parkinson's disease	0.000126	0.000928	CbGeAlD
Bosutinib—CSF1R—medulla oblongata—Parkinson's disease	0.000126	0.000927	CbGeAlD
Bosutinib—MAP4K4—brain—Parkinson's disease	0.000126	0.000927	CbGeAlD
Bosutinib—IRAK1—cerebellum—Parkinson's disease	0.000125	0.000925	CbGeAlD
Bosutinib—FGR—central nervous system—Parkinson's disease	0.000125	0.000923	CbGeAlD
Bosutinib—MAP4K5—head—Parkinson's disease	0.000125	0.000921	CbGeAlD
Bosutinib—MAP3K3—head—Parkinson's disease	0.000125	0.000921	CbGeAlD
Bosutinib—SRC—spinal cord—Parkinson's disease	0.000125	0.00092	CbGeAlD
Bosutinib—NUAK2—brain—Parkinson's disease	0.000125	0.00092	CbGeAlD
Bosutinib—BCR—brain—Parkinson's disease	0.000125	0.00092	CbGeAlD
Bosutinib—AXL—central nervous system—Parkinson's disease	0.000125	0.000919	CbGeAlD
Bosutinib—MAP3K12—brain—Parkinson's disease	0.000124	0.000913	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—Parkinson's disease	0.000123	0.000907	CbGeAlD
Bosutinib—AXL—cerebellum—Parkinson's disease	0.000122	0.000898	CbGeAlD
Bosutinib—MAP2K1—brain—Parkinson's disease	0.000121	0.000895	CbGeAlD
Bosutinib—STK35—brain—Parkinson's disease	0.000121	0.000895	CbGeAlD
Bosutinib—EPHA2—nervous system—Parkinson's disease	0.000121	0.000895	CbGeAlD
Bosutinib—FYN—nervous system—Parkinson's disease	0.000121	0.000893	CbGeAlD
Bosutinib—CSK—brain—Parkinson's disease	0.000121	0.000889	CbGeAlD
Bosutinib—CSNK1A1—brain—Parkinson's disease	0.00012	0.000883	CbGeAlD
Bosutinib—CLK1—brain—Parkinson's disease	0.000119	0.000878	CbGeAlD
Bosutinib—HCK—brain—Parkinson's disease	0.000119	0.000878	CbGeAlD
Bosutinib—MAP4K5—nervous system—Parkinson's disease	0.000118	0.000873	CbGeAlD
Bosutinib—MAP3K3—nervous system—Parkinson's disease	0.000118	0.000873	CbGeAlD
Bosutinib—ABL2—brain—Parkinson's disease	0.000118	0.000872	CbGeAlD
Bosutinib—MAP2K5—midbrain—Parkinson's disease	0.000118	0.000868	CbGeAlD
Bosutinib—SLK—cerebellum—Parkinson's disease	0.000117	0.000865	CbGeAlD
Bosutinib—EPHA2—central nervous system—Parkinson's disease	0.000117	0.000861	CbGeAlD
Bosutinib—BMP2K—brain—Parkinson's disease	0.000117	0.000861	CbGeAlD
Bosutinib—CAMK2G—brain—Parkinson's disease	0.000117	0.000861	CbGeAlD
Bosutinib—FYN—central nervous system—Parkinson's disease	0.000117	0.00086	CbGeAlD
Bosutinib—EPHB4—cerebellum—Parkinson's disease	0.000116	0.000858	CbGeAlD
Bosutinib—ABL1—cardiovascular system—Parkinson's disease	0.000116	0.000857	CbGeAlD
Bosutinib—LRRK2—brain—Parkinson's disease	0.000116	0.000854	CbGeAlD
Bosutinib—EGFR—brain—Parkinson's disease	0.000115	0.000851	CbGeAlD
Bosutinib—YES1—head—Parkinson's disease	0.000115	0.00085	CbGeAlD
Bosutinib—CSF1R—midbrain—Parkinson's disease	0.000115	0.000847	CbGeAlD
Bosutinib—MAP2K5—spinal cord—Parkinson's disease	0.000115	0.000847	CbGeAlD
Bosutinib—STK10—head—Parkinson's disease	0.000114	0.000843	CbGeAlD
Bosutinib—FYN—cerebellum—Parkinson's disease	0.000114	0.000841	CbGeAlD
Bosutinib—MAP4K5—central nervous system—Parkinson's disease	0.000114	0.00084	CbGeAlD
Bosutinib—MAP3K3—central nervous system—Parkinson's disease	0.000114	0.00084	CbGeAlD
Bosutinib—TAOK3—head—Parkinson's disease	0.000114	0.000839	CbGeAlD
Bosutinib—PTK2B—brain—Parkinson's disease	0.000113	0.000832	CbGeAlD
Bosutinib—CSF1R—spinal cord—Parkinson's disease	0.000112	0.000826	CbGeAlD
Bosutinib—PDGFRB—medulla oblongata—Parkinson's disease	0.000111	0.000822	CbGeAlD
Bosutinib—MAP4K5—cerebellum—Parkinson's disease	0.000111	0.000821	CbGeAlD
Bosutinib—MAP3K3—cerebellum—Parkinson's disease	0.000111	0.000821	CbGeAlD
Bosutinib—CSNK1E—brain—Parkinson's disease	0.000111	0.000818	CbGeAlD
Bosutinib—SRC—head—Parkinson's disease	0.000111	0.000818	CbGeAlD
Bosutinib—YES1—nervous system—Parkinson's disease	0.000109	0.000806	CbGeAlD
Bosutinib—SIK1—brain—Parkinson's disease	0.000109	0.000806	CbGeAlD
Bosutinib—IRAK4—brain—Parkinson's disease	0.000109	0.000806	CbGeAlD
Bosutinib—STK10—nervous system—Parkinson's disease	0.000108	0.000799	CbGeAlD
Bosutinib—EPHA4—brain—Parkinson's disease	0.000108	0.000798	CbGeAlD
Bosutinib—TAOK3—nervous system—Parkinson's disease	0.000108	0.000796	CbGeAlD
Bosutinib—ERBB3—brain—Parkinson's disease	0.000107	0.00079	CbGeAlD
Bosutinib—ULK3—brain—Parkinson's disease	0.000107	0.000788	CbGeAlD
Bosutinib—MAP2K2—brain—Parkinson's disease	0.000107	0.000788	CbGeAlD
Bosutinib—MAP3K2—brain—Parkinson's disease	0.000106	0.000782	CbGeAlD
Bosutinib—YES1—central nervous system—Parkinson's disease	0.000105	0.000776	CbGeAlD
Bosutinib—SRC—nervous system—Parkinson's disease	0.000105	0.000776	CbGeAlD
Bosutinib—MAP3K7—brain—Parkinson's disease	0.000105	0.000775	CbGeAlD
Bosutinib—STK10—central nervous system—Parkinson's disease	0.000104	0.000769	CbGeAlD
Bosutinib—TAOK3—central nervous system—Parkinson's disease	0.000104	0.000766	CbGeAlD
Bosutinib—PTK2—brain—Parkinson's disease	0.000104	0.000766	CbGeAlD
Bosutinib—TBK1—brain—Parkinson's disease	0.000104	0.000766	CbGeAlD
Bosutinib—YES1—cerebellum—Parkinson's disease	0.000103	0.000759	CbGeAlD
Bosutinib—MAP2K5—head—Parkinson's disease	0.000102	0.000753	CbGeAlD
Bosutinib—STK10—cerebellum—Parkinson's disease	0.000102	0.000752	CbGeAlD
Bosutinib—PDGFRB—midbrain—Parkinson's disease	0.000102	0.000751	CbGeAlD
Bosutinib—IRAK1—brain—Parkinson's disease	0.000102	0.000751	CbGeAlD
Bosutinib—TAOK3—cerebellum—Parkinson's disease	0.000102	0.000749	CbGeAlD
Bosutinib—SRC—central nervous system—Parkinson's disease	0.000101	0.000747	CbGeAlD
Bosutinib—RPS6KB1—brain—Parkinson's disease	9.99e-05	0.000737	CbGeAlD
Bosutinib—CSF1R—head—Parkinson's disease	9.96e-05	0.000734	CbGeAlD
Bosutinib—PDGFRB—spinal cord—Parkinson's disease	9.93e-05	0.000733	CbGeAlD
Bosutinib—ABL1—medulla oblongata—Parkinson's disease	9.93e-05	0.000733	CbGeAlD
Bosutinib—FGR—brain—Parkinson's disease	9.93e-05	0.000732	CbGeAlD
Bosutinib—SRC—cerebellum—Parkinson's disease	9.89e-05	0.00073	CbGeAlD
Bosutinib—AXL—brain—Parkinson's disease	9.89e-05	0.00073	CbGeAlD
Bosutinib—MAP2K5—nervous system—Parkinson's disease	9.67e-05	0.000713	CbGeAlD
Bosutinib—SLK—brain—Parkinson's disease	9.52e-05	0.000702	CbGeAlD
Bosutinib—EPHB4—brain—Parkinson's disease	9.45e-05	0.000697	CbGeAlD
Bosutinib—CSF1R—nervous system—Parkinson's disease	9.44e-05	0.000696	CbGeAlD
Bosutinib—MAP2K5—central nervous system—Parkinson's disease	9.31e-05	0.000687	CbGeAlD
Bosutinib—EPHA2—brain—Parkinson's disease	9.27e-05	0.000684	CbGeAlD
Bosutinib—FYN—brain—Parkinson's disease	9.26e-05	0.000683	CbGeAlD
Bosutinib—MAP2K5—cerebellum—Parkinson's disease	9.1e-05	0.000671	CbGeAlD
Bosutinib—CSF1R—central nervous system—Parkinson's disease	9.09e-05	0.00067	CbGeAlD
Bosutinib—ABL1—midbrain—Parkinson's disease	9.08e-05	0.000669	CbGeAlD
Bosutinib—MAP4K5—brain—Parkinson's disease	9.04e-05	0.000667	CbGeAlD
Bosutinib—MAP3K3—brain—Parkinson's disease	9.04e-05	0.000667	CbGeAlD
Bosutinib—CSF1R—cerebellum—Parkinson's disease	8.88e-05	0.000655	CbGeAlD
Bosutinib—ABL1—spinal cord—Parkinson's disease	8.85e-05	0.000653	CbGeAlD
Bosutinib—PDGFRB—head—Parkinson's disease	8.83e-05	0.000651	CbGeAlD
Bosutinib—PDGFRB—nervous system—Parkinson's disease	8.37e-05	0.000618	CbGeAlD
Bosutinib—YES1—brain—Parkinson's disease	8.35e-05	0.000616	CbGeAlD
Bosutinib—STK10—brain—Parkinson's disease	8.28e-05	0.000611	CbGeAlD
Bosutinib—TAOK3—brain—Parkinson's disease	8.25e-05	0.000608	CbGeAlD
Bosutinib—PDGFRB—central nervous system—Parkinson's disease	8.06e-05	0.000595	CbGeAlD
Bosutinib—SRC—brain—Parkinson's disease	8.04e-05	0.000593	CbGeAlD
Bosutinib—PDGFRB—cerebellum—Parkinson's disease	7.88e-05	0.000581	CbGeAlD
Bosutinib—ABL1—head—Parkinson's disease	7.87e-05	0.000581	CbGeAlD
Bosutinib—ABL1—nervous system—Parkinson's disease	7.46e-05	0.00055	CbGeAlD
Bosutinib—MAP2K5—brain—Parkinson's disease	7.39e-05	0.000545	CbGeAlD
Bosutinib—CSF1R—brain—Parkinson's disease	7.21e-05	0.000532	CbGeAlD
Bosutinib—ABL1—central nervous system—Parkinson's disease	7.18e-05	0.00053	CbGeAlD
Bosutinib—ABL1—cerebellum—Parkinson's disease	7.02e-05	0.000518	CbGeAlD
Bosutinib—PDGFRB—brain—Parkinson's disease	6.4e-05	0.000472	CbGeAlD
Bosutinib—ABL1—brain—Parkinson's disease	5.7e-05	0.000421	CbGeAlD
Bosutinib—ABCB1—embryo—Parkinson's disease	4.83e-05	0.000356	CbGeAlD
Bosutinib—ABCB1—forebrain—Parkinson's disease	4.27e-05	0.000315	CbGeAlD
Bosutinib—ABCB1—cardiovascular system—Parkinson's disease	3.61e-05	0.000267	CbGeAlD
Bosutinib—CYP3A4—nervous system—Parkinson's disease	3.28e-05	0.000242	CbGeAlD
Bosutinib—CYP3A4—central nervous system—Parkinson's disease	3.16e-05	0.000233	CbGeAlD
Bosutinib—ABCB1—medulla oblongata—Parkinson's disease	3.09e-05	0.000228	CbGeAlD
Bosutinib—ABCB1—midbrain—Parkinson's disease	2.82e-05	0.000208	CbGeAlD
Bosutinib—ABCB1—spinal cord—Parkinson's disease	2.75e-05	0.000203	CbGeAlD
Bosutinib—ABCB1—head—Parkinson's disease	2.45e-05	0.000181	CbGeAlD
Bosutinib—ABCB1—nervous system—Parkinson's disease	2.32e-05	0.000171	CbGeAlD
Bosutinib—ABCB1—central nervous system—Parkinson's disease	2.23e-05	0.000165	CbGeAlD
Bosutinib—ABCB1—cerebellum—Parkinson's disease	2.18e-05	0.000161	CbGeAlD
Bosutinib—ABCB1—brain—Parkinson's disease	1.77e-05	0.000131	CbGeAlD
Bosutinib—PDGFRB—Disease—INS—Parkinson's disease	1.92e-06	9.76e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IGF1R—Parkinson's disease	1.92e-06	9.75e-06	CbGpPWpGaD
Bosutinib—TBK1—Immune System—IL6—Parkinson's disease	1.92e-06	9.73e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD3—Parkinson's disease	1.9e-06	9.65e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EDN1—Parkinson's disease	1.9e-06	9.63e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—MAPK8—Parkinson's disease	1.9e-06	9.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IGF1R—Parkinson's disease	1.89e-06	9.6e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.89e-06	9.59e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IGF1R—Parkinson's disease	1.88e-06	9.55e-06	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—IL6—Parkinson's disease	1.88e-06	9.55e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—APOE—Parkinson's disease	1.87e-06	9.52e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—MAPK8—Parkinson's disease	1.87e-06	9.5e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOB—Parkinson's disease	1.87e-06	9.49e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EDN1—Parkinson's disease	1.87e-06	9.48e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.86e-06	9.46e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DBH—Parkinson's disease	1.86e-06	9.46e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GBA—Parkinson's disease	1.86e-06	9.46e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EDN1—Parkinson's disease	1.86e-06	9.43e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—INS—Parkinson's disease	1.85e-06	9.41e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—APOE—Parkinson's disease	1.85e-06	9.38e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—INS—Parkinson's disease	1.84e-06	9.36e-06	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—IL6—Parkinson's disease	1.84e-06	9.32e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—IL6—Parkinson's disease	1.83e-06	9.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—Parkinson's disease	1.83e-06	9.27e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NGF—Parkinson's disease	1.83e-06	9.27e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL1B—Parkinson's disease	1.82e-06	9.25e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—IL6—Parkinson's disease	1.81e-06	9.2e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—MAPK8—Parkinson's disease	1.81e-06	9.18e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—APOE—Parkinson's disease	1.81e-06	9.17e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—INS—Parkinson's disease	1.79e-06	9.1e-06	CbGpPWpGaD
Bosutinib—BTK—Immune System—IL6—Parkinson's disease	1.79e-06	9.07e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NGF—Parkinson's disease	1.78e-06	9.04e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADRBK1—Parkinson's disease	1.78e-06	9.02e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—MAPK8—Parkinson's disease	1.78e-06	9.01e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—INS—Parkinson's disease	1.77e-06	8.98e-06	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—IL6—Parkinson's disease	1.76e-06	8.94e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NGF—Parkinson's disease	1.74e-06	8.85e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—MAPK8—Parkinson's disease	1.74e-06	8.83e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR2A—Parkinson's disease	1.74e-06	8.82e-06	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—IL6—Parkinson's disease	1.73e-06	8.79e-06	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—IL6—Parkinson's disease	1.72e-06	8.75e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD2—Parkinson's disease	1.72e-06	8.73e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR7—Parkinson's disease	1.72e-06	8.73e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—MTHFR—Parkinson's disease	1.72e-06	8.72e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NGF—Parkinson's disease	1.72e-06	8.72e-06	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—IL6—Parkinson's disease	1.71e-06	8.7e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NGF—Parkinson's disease	1.71e-06	8.67e-06	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—IL6—Parkinson's disease	1.71e-06	8.67e-06	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—IL6—Parkinson's disease	1.71e-06	8.66e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CASP3—Parkinson's disease	1.7e-06	8.64e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—IL6—Parkinson's disease	1.7e-06	8.61e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR2A—Parkinson's disease	1.7e-06	8.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IGF2—Parkinson's disease	1.69e-06	8.58e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—INS—Parkinson's disease	1.68e-06	8.51e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CASP3—Parkinson's disease	1.68e-06	8.51e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—MAPK8—Parkinson's disease	1.67e-06	8.48e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR2A—Parkinson's disease	1.66e-06	8.43e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—IL6—Parkinson's disease	1.65e-06	8.37e-06	CbGpPWpGaD
Bosutinib—HCK—Immune System—IL6—Parkinson's disease	1.64e-06	8.32e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR2A—Parkinson's disease	1.63e-06	8.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IGF1R—Parkinson's disease	1.63e-06	8.29e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IGF2—Parkinson's disease	1.63e-06	8.27e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR2A—Parkinson's disease	1.63e-06	8.25e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—APOE—Parkinson's disease	1.62e-06	8.2e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CASP3—Parkinson's disease	1.62e-06	8.2e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EDN1—Parkinson's disease	1.61e-06	8.19e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—IL6—Parkinson's disease	1.6e-06	8.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—INS—Parkinson's disease	1.6e-06	8.13e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—IL6—Parkinson's disease	1.6e-06	8.13e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—APOE—Parkinson's disease	1.6e-06	8.12e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL1B—Parkinson's disease	1.59e-06	8.09e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—INS—Parkinson's disease	1.58e-06	8.02e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—APOE—Parkinson's disease	1.58e-06	8e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IGF1R—Parkinson's disease	1.57e-06	7.99e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MAPK8—Parkinson's disease	1.56e-06	7.94e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—IL6—Parkinson's disease	1.56e-06	7.93e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—Parkinson's disease	1.56e-06	7.91e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CASP3—Parkinson's disease	1.56e-06	7.9e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CASP3—Parkinson's disease	1.56e-06	7.9e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EDN1—Parkinson's disease	1.56e-06	7.9e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL1B—Parkinson's disease	1.55e-06	7.89e-06	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—IL6—Parkinson's disease	1.54e-06	7.84e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—APOE—Parkinson's disease	1.54e-06	7.83e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—INS—Parkinson's disease	1.54e-06	7.83e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MAPK8—Parkinson's disease	1.54e-06	7.82e-06	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—IL6—Parkinson's disease	1.53e-06	7.77e-06	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—IL6—Parkinson's disease	1.52e-06	7.73e-06	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—IL6—Parkinson's disease	1.52e-06	7.73e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL1B—Parkinson's disease	1.52e-06	7.73e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—APOE—Parkinson's disease	1.52e-06	7.71e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL1B—Parkinson's disease	1.51e-06	7.69e-06	CbGpPWpGaD
Bosutinib—HCK—Disease—IL6—Parkinson's disease	1.51e-06	7.68e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—APOE—Parkinson's disease	1.51e-06	7.67e-06	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—IL6—Parkinson's disease	1.51e-06	7.65e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CASP3—Parkinson's disease	1.5e-06	7.61e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL1B—Parkinson's disease	1.5e-06	7.61e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—IL6—Parkinson's disease	1.5e-06	7.61e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL1B—Parkinson's disease	1.49e-06	7.56e-06	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL6—Parkinson's disease	1.49e-06	7.54e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MAPK8—Parkinson's disease	1.48e-06	7.53e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NGF—Parkinson's disease	1.48e-06	7.53e-06	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL6—Parkinson's disease	1.48e-06	7.52e-06	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—IL6—Parkinson's disease	1.47e-06	7.48e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—MAPK8—Parkinson's disease	1.46e-06	7.41e-06	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL6—Parkinson's disease	1.46e-06	7.4e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF2—Parkinson's disease	1.44e-06	7.32e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MAPK8—Parkinson's disease	1.43e-06	7.26e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MAPK8—Parkinson's disease	1.43e-06	7.26e-06	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL6—Parkinson's disease	1.43e-06	7.26e-06	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL6—Parkinson's disease	1.43e-06	7.26e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NGF—Parkinson's disease	1.43e-06	7.26e-06	CbGpPWpGaD
Bosutinib—ERBB4—Disease—IL6—Parkinson's disease	1.43e-06	7.24e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—MAPK8—Parkinson's disease	1.43e-06	7.24e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2A—Parkinson's disease	1.41e-06	7.17e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—MAPK8—Parkinson's disease	1.4e-06	7.08e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1R—Parkinson's disease	1.39e-06	7.07e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.39e-06	7.05e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—MAPK8—Parkinson's disease	1.39e-06	7.05e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—Parkinson's disease	1.38e-06	7.01e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—INS—Parkinson's disease	1.38e-06	7.01e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MAPK8—Parkinson's disease	1.38e-06	7e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EDN1—Parkinson's disease	1.38e-06	6.99e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—MAPK8—Parkinson's disease	1.37e-06	6.97e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—DDC—Parkinson's disease	1.37e-06	6.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—MAPK8—Parkinson's disease	1.37e-06	6.94e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—INS—Parkinson's disease	1.37e-06	6.94e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CTGF—Parkinson's disease	1.36e-06	6.92e-06	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—Parkinson's disease	1.36e-06	6.91e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2A—Parkinson's disease	1.36e-06	6.91e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—INS—Parkinson's disease	1.35e-06	6.84e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CASP3—Parkinson's disease	1.34e-06	6.78e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—INS—Parkinson's disease	1.32e-06	6.69e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CASP3—Parkinson's disease	1.32e-06	6.68e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOE—Parkinson's disease	1.31e-06	6.66e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—Parkinson's disease	1.3e-06	6.61e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—INS—Parkinson's disease	1.3e-06	6.59e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—Parkinson's disease	1.29e-06	6.57e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.29e-06	6.56e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—INS—Parkinson's disease	1.29e-06	6.55e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.27e-06	6.45e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NGF—Parkinson's disease	1.27e-06	6.42e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOE—Parkinson's disease	1.27e-06	6.42e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—Parkinson's disease	1.26e-06	6.38e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—Parkinson's disease	1.26e-06	6.38e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NQO1—Parkinson's disease	1.26e-06	6.38e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—Parkinson's disease	1.25e-06	6.37e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CASP3—Parkinson's disease	1.25e-06	6.34e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—Parkinson's disease	1.25e-06	6.33e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—TH—Parkinson's disease	1.24e-06	6.29e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MAPK8—Parkinson's disease	1.23e-06	6.23e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—Parkinson's disease	1.21e-06	6.15e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MAPK8—Parkinson's disease	1.21e-06	6.14e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—Parkinson's disease	1.2e-06	6.12e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—Parkinson's disease	1.2e-06	6.07e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYCS—Parkinson's disease	1.19e-06	6.04e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—MAPK8—Parkinson's disease	1.19e-06	6.03e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CASP3—Parkinson's disease	1.18e-06	5.97e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.16e-06	5.91e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—Parkinson's disease	1.16e-06	5.86e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.15e-06	5.85e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MAPK8—Parkinson's disease	1.15e-06	5.83e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—MAPK8—Parkinson's disease	1.14e-06	5.81e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—Parkinson's disease	1.13e-06	5.75e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—INS—Parkinson's disease	1.12e-06	5.69e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOE—Parkinson's disease	1.12e-06	5.69e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—Parkinson's disease	1.11e-06	5.64e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—Parkinson's disease	1.1e-06	5.61e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—INS—Parkinson's disease	1.08e-06	5.49e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MAPK8—Parkinson's disease	1.08e-06	5.49e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—Parkinson's disease	1.07e-06	5.42e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—COMT—Parkinson's disease	1.05e-06	5.35e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.05e-06	5.32e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOA—Parkinson's disease	1.05e-06	5.31e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.03e-06	5.25e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CASP3—Parkinson's disease	1.03e-06	5.22e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—Parkinson's disease	1.02e-06	5.18e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MAPK8—Parkinson's disease	1.01e-06	5.14e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CASP3—Parkinson's disease	1e-06	5.09e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—Parkinson's disease	9.99e-07	5.07e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—Parkinson's disease	9.84e-07	5e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CASP3—Parkinson's disease	9.82e-07	4.98e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CASP3—Parkinson's disease	9.67e-07	4.91e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GSTM1—Parkinson's disease	9.63e-07	4.89e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CASP3—Parkinson's disease	9.61e-07	4.88e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—INS—Parkinson's disease	9.57e-07	4.86e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—Parkinson's disease	9.55e-07	4.85e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—Parkinson's disease	9.48e-07	4.81e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MAPK8—Parkinson's disease	9.44e-07	4.79e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—Parkinson's disease	9.33e-07	4.73e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GPX1—Parkinson's disease	9.22e-07	4.68e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAPK8—Parkinson's disease	9.22e-07	4.68e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—Parkinson's disease	9.13e-07	4.64e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—Parkinson's disease	9.13e-07	4.64e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—Parkinson's disease	9.1e-07	4.62e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAPK8—Parkinson's disease	9.02e-07	4.58e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—Parkinson's disease	8.91e-07	4.52e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAPK8—Parkinson's disease	8.88e-07	4.51e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—Parkinson's disease	8.87e-07	4.5e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAPK8—Parkinson's disease	8.84e-07	4.48e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—Parkinson's disease	8.8e-07	4.47e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—Parkinson's disease	8.77e-07	4.45e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—Parkinson's disease	8.73e-07	4.43e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—Parkinson's disease	8.61e-07	4.37e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.56e-07	4.35e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—Parkinson's disease	8.51e-07	4.32e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—Parkinson's disease	8.4e-07	4.27e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.4e-07	4.27e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CASP3—Parkinson's disease	8.35e-07	4.24e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—Parkinson's disease	8.3e-07	4.21e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—Parkinson's disease	8.1e-07	4.11e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—Parkinson's disease	8.06e-07	4.09e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CASP3—Parkinson's disease	8.05e-07	4.08e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—Parkinson's disease	7.92e-07	4.02e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—Parkinson's disease	7.84e-07	3.98e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.83e-07	3.97e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.74e-07	3.93e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—Parkinson's disease	7.73e-07	3.92e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAPK8—Parkinson's disease	7.67e-07	3.9e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TH—Parkinson's disease	7.63e-07	3.87e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—Parkinson's disease	7.58e-07	3.85e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAPK8—Parkinson's disease	7.4e-07	3.75e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—Parkinson's disease	7.33e-07	3.72e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.33e-07	3.72e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—Parkinson's disease	7.3e-07	3.71e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CASP3—Parkinson's disease	7.12e-07	3.62e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—Parkinson's disease	7e-07	3.55e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—Parkinson's disease	6.9e-07	3.5e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INS—Parkinson's disease	6.77e-07	3.44e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—Parkinson's disease	6.74e-07	3.42e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAPK8—Parkinson's disease	6.55e-07	3.32e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—COMT—Parkinson's disease	6.49e-07	3.29e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—Parkinson's disease	6.47e-07	3.28e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.46e-07	3.28e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.44e-07	3.27e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.37e-07	3.23e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.11e-07	3.1e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—Parkinson's disease	6.03e-07	3.06e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—Parkinson's disease	5.97e-07	3.03e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.93e-07	3.01e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—Parkinson's disease	5.89e-07	2.99e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—Parkinson's disease	5.76e-07	2.92e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.68e-07	2.88e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—Parkinson's disease	5.67e-07	2.88e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—Parkinson's disease	5.64e-07	2.86e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.24e-07	2.66e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—Parkinson's disease	4.9e-07	2.49e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—Parkinson's disease	4.88e-07	2.48e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—Parkinson's disease	4.72e-07	2.4e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—Parkinson's disease	4.18e-07	2.12e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INS—Parkinson's disease	4.17e-07	2.12e-06	CbGpPWpGaD
